A partner would be my vote. This would carry a huge boost to our reputation and would most likely prove our molecule with big pharma. This could create FOMO for the share price. Amarex will happen some day and be a great payday, but it is largely unknown to the investment community as this issue is OTC stock squabble. Of course HIH is welcomed but I think the best impression is with a partner.